[1]
Babiarczyk, B. et al. 2025. Quality of life of patients with diabeticretinopathy receiving anti-VEGF therapy. Nursing in the 21st Century. 24, 3(92) (Sep. 2025), 241–249. DOI:https://doi.org/10.12923/pielxxiw-2025-0025.